Xylem Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.04B | $8.56B | $7.36B | $5.52B | $5.20B | $4.88B | $5.25B | $5.21B |
| Cost of Revenue | $5.56B | $5.35B | $4.65B | $3.44B | $3.22B | $3.05B | $3.20B | $3.18B |
| Gross Profit | $3.48B | $3.21B | $2.72B | $2.08B | $1.98B | $1.83B | $2.05B | $2.03B |
| Gross Margin | 38.5% | 37.5% | 36.9% | 37.7% | 38.0% | 37.5% | 39.0% | 38.9% |
| Operating Expenses | ||||||||
| Research & Development | $226.0M | $230.0M | $232.0M | $206.0M | $204.0M | $187.0M | $191.0M | $189.0M |
| SG&A Expense | $1.92B | $1.91B | $1.76B | $1.23B | $1.18B | $1.14B | $1.16B | $1.16B |
| Operating Income | $1.22B | $1.01B | $652.0M | $622.0M | $585.0M | $367.0M | $486.0M | $654.0M |
| Operating Margin | 13.5% | 11.8% | 8.9% | 11.3% | 11.3% | 7.5% | 9.3% | 12.6% |
| Interest Expense | — | — | $49.0M | $50.0M | $76.0M | $77.0M | $67.0M | $82.0M |
| Pretax Income | $1.18B | $1.09B | $635.0M | $440.0M | $511.0M | $285.0M | $416.0M | $585.0M |
| Income Tax Expense | $231.0M | $197.0M | $26.0M | $85.0M | $84.0M | $31.0M | $15.0M | $36.0M |
| Net Income | $957.0M | $890.0M | $609.0M | $355.0M | $427.0M | $254.0M | $401.0M | $549.0M |
| Net Margin | 10.6% | 10.4% | 8.3% | 6.4% | 8.2% | 5.2% | 7.6% | 10.5% |
| EPS (Basic) | $3.93 | $3.67 | $2.81 | $1.97 | $2.37 | $1.41 | $2.23 | $3.05 |
| EPS (Diluted) | $3.92 | $3.65 | $2.79 | $1.96 | $2.35 | $1.40 | $2.21 | $3.03 |
| Shares Outstanding (Basic) | 243.4M | 242.6M | 217.0M | 180.2M | 180.2M | 180.1M | 180.0M | 179.8M |
| Shares Outstanding (Diluted) | 244.0M | 243.5M | 218.2M | 181.0M | 181.5M | 181.1M | 181.2M | 181.1M |
| Dividends Per Share | $1.60 | $1.44 | $1.32 | $1.20 | $1.12 | $1.04 | $0.96 | $0.84 |